Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FWUVR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,116
Award facts
- Contract value 100% obligated
- $12,115.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 by the Defense Logistics Agency on August 12, 2025, for the supply of Jakafi 10 mg tablets (60-count). This delivery order was issued without a set-aside designation and carries an ultimate completion date of August 13, 2025. The award represents a task order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.99 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to compete effectively in DLA procurement markets. The company specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to military and federal healthcare systems nationwide. This particular delivery order for Jakafi, an oral medication indicated for myelofibrosis and polycythemia vera, exemplifies the company's role in supplying specialized pharmaceutical products that support the medical needs of military health facilities across the DoD enterprise.
Quick answers
Who was awarded contract SPE2DB25FWUVR?
SPE2DB25FWUVR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FWUVR worth?
The government has obligated $12,116 on SPE2DB25FWUVR.
Is contract SPE2DB25FWUVR an order under another contract?
Yes. SPE2DB25FWUVR is a delivery order under SPE2DB25D9312, an indefinite delivery contract.
Was contract SPE2DB25FWUVR competed?
The extent of competition for SPE2DB25FWUVR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award